Firefly Neuroscience Reports Director/Officer Changes
Ticker: AIFF · Form: 8-K · Filed: Dec 3, 2024 · CIK: 803578
Sentiment: neutral
Topics: management-change, corporate-governance
TL;DR
Firefly Neuroscience filed an 8-K for director/officer changes as of Nov 30.
AI Summary
Firefly Neuroscience, Inc. filed an 8-K on December 3, 2024, reporting on events as of November 30, 2024. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding these changes were not provided in the excerpt.
Why It Matters
Changes in a company's board of directors or executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key personnel can indicate underlying issues or strategic shifts that may impact the company's future performance.
Key Players & Entities
- FIREFLY NEUROSCIENCE, INC. (company) — Registrant
- November 30, 2024 (date) — Earliest event reported date
- December 3, 2024 (date) — Filing date
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, election of directors, and appointment of certain officers, but the specific details of these changes are not provided in the excerpt.
What is the exact date of the events reported in this 8-K?
The earliest event reported in this 8-K is as of November 30, 2024.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on December 3, 2024.
What is the company's state of incorporation?
Firefly Neuroscience, Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The principal executive offices are located at 1100 Military Road, Kenmore, NY 14217.
Filing Stats: 746 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-12-03 17:04:09
Key Financial Figures
- $0.0001 — on which registered Common Stock , $0.0001 par value per share AIFF The Nasdaq
- $1 billion — firm. Mr. Lipschitz has advised on over $1 billion of transactions. Mr. Lipschitz is a Cha
- $950,000 — d to receive aggregate consideration of $950,000 in shares of common stock of the Compan
- $316,667 — Lipschitz Agreement comprised of up to $316,667 of annual service credits over three ye
Filing Documents
- wavd20241203_8k.htm (8-K) — 29KB
- 0001437749-24-036585.txt ( ) — 158KB
- wavd-20241130.xsd (EX-101.SCH) — 3KB
- wavd-20241130_def.xml (EX-101.DEF) — 11KB
- wavd-20241130_lab.xml (EX-101.LAB) — 15KB
- wavd-20241130_pre.xml (EX-101.PRE) — 11KB
- wavd20241203_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FIREFLY NEUROSCIENCE, INC. Date: December 3, 2024 By: /s/ Jon Olsen Name: Jon Olsen Title: Chief Executive Officer